Abstract
Topical corticosteroids are widely used for inflammatory and hyperproliferative disorders in dermatology. Numerous topical corticosteroids with high local activity have been developed over the years, with a focus to develop drugs with high efficacy locally and minimum risk for adverse drug reactions. They are available in a number of formulations. Their therapeutic effects are a result of their anti-inflammatory, immunosuppressant, vasoconstrictive and anti-proliferative actions. An appropriate topical corticosteroid is selected on the basis of the dermatological condition to be treated, patient-related factors and the physicochemical properties of the drug. Their use is associated with mainly local adverse drug reactions, but prolonged use and/or use of high-potency topical corticosteroids may cause systemic effects.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19(2):101–2.
Schimmer BP, Funder WH. ACTH, adrenal steroids, and pharmacology of the adrenal cortex. In: Brunton LL, editor. Pharmacological basis of therapeutics. 13th ed. New York, NY: McGraw-Hill. p. 1209–36.
Goldman L, Thomson RG, Trice ER. Cortisone acetate in skin disease: local effect in skin from topical applicants and local injections. AMA Arch Dermatol Syph. 1952;101-2(2):19.
Murray JR. The history of corticosteroids. Acta Derm Venereol. 1989;69(Suppl 151):4–6.
Katz M, Gans EH. Topical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development—a process of “planned serendipity”. J Pharm Sci. 2008;97:2936–47.
Yohn JJ. WestonW.L. Topical glucocorticosteroids. Curr Probl Dermatol. 1990;2:31–63.
Warner MR, Camisa C. Topical corticosteroids. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 3rd ed. New York, NY: Elsevier Health. p. 487–504.
Brazzini B, Pimpinelli N. New and established corticosteroids in dermatology. Am J Clin Dermatol. 2002;3:47–58.
Chrousos GP. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, Trevor AJ, editors. Basic and clinical pharmacology. 13th ed. New York, NY: McGraw Hill; 2015. p. 680–95. www.accesspharmacy.com.
McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol. 1962;86:608–10.
Cornell RC. Clinical trials of topical corticosteroids in psoriasis: correlations with the vasoconstrictor assay. Int J Dermatol. 1992;31(Suppl 1):38–40.
Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol. 1985;121:63–7.
Drake L, Dinehart S, Farmer E, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol. 1996;35:615–9.
Hepburn DJ, Aeling JL, Weston WL. A reappraisal of topical steroid potency. Pediatr Dermatol. 1996;13:239–45.
Humbert P, Guichard A. The topical corticosteroid classification called into question: towards a new approach. Exp Dermatol. 2015;24:393–4.
Dumas KJ, Scholtz JR. The psoriasis bio-assay for topical corticosteroid activity. Acta Derm Venereol. 1972;52:43–8.
WHO model prescribing information: drugs used in skin diseases: Annex: Classification of topical corticosteroids. [Internet] [cited 13 Jan 2017]. Available from: http://apps.who.int/medicinedocs/en/d/Jh2918e/32.html#Jh2918e.32.1.
British National Formulary (BNF). 69th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; March 2015.
Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids. 2002;67(6):529–34.
Ponec M, Kempenaar JA, De Kloet ER. Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy. J Invest Dermatol. 1981;76:211–4.
Marks R, Barlow JW, Funder JW. Steroid-induced vasoconstriction:glucocorticoid antagonist studies. J Clin Endocrinol Metab. 1982;54:1075–7.
Mc Master A, Ray DW. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat Clin Pract Endocrinol Metab. 2008;4:91–101.
Schacke H, Rehwinkel H, Asadullah K, Cato AC. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp Dermatol. 2006;15:565–73.
Buttgereit F, Straub RH, Wehling M, Burmester GR. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum. 2004;50:3408–17.
Croxtall JD, Choudhury Q, Flower RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol. 2000;130:289–98.
Burkholder B. Topical corticosteroids: An update. Curr Probl Dermatol. 2000;12:222–5.
Mori M, Pimpinelli N, Giannotti B. Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio. Drug Saf. 1994;10:406–12.
Ahluwalia A. Topical glucocorticoids and the skin-mechanisms of action: an update. Mediat Inflamm. 1998;7:183–93.
Buttgereit F, Saag KG, Cutolo M, Silva JAP, Bijlsma JWJ. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol. 2005;34:14–21.
Altura BM. Role of glucocorticosteroids in local regulation of blood flow. Am J Phys. 1966;211:1393.
Hein R, Krieg T. Effects of corticosteroids on human fibroblasts in-vitro. In: Chrostophers E, Schopf E, Kligman AM, et al., editors. Topical corticosteroid therapy: a novel approach to safer drugs. New York, NY: Raven Press; 1988. p. 57–65.
Robertson DB, Maibach HI. Dermatologic pharmacology. In: Katzung BG, Trevor AJ, editors. Basic and clinical pharmacology. 13th ed. New Delhi: McGraw Hill; 2015. p. 1033–51.
Lee NP, Ariola ER. Topical corticosteroids: back to basics. West J Med. 1999;171:351–3.
Ayres PJ, Hooper G. Assessment of the skin penetration properties of different carrier vehicles for topically applied cortisol. Br J Dermatol. 1978;307-17(5):99.
Fang JY, Leu YL, Wang YY, Tsai YH. In vitro topical application and in vivo pharmacodynamic evaluation of Nonivamide hydrogels using Wistar rat as an animal model. Eur J Pharm Sci. 2002;15:417–23.
Senyigit T, Ozer O. Corticosteroids for skin delivery: challenges and new formulation opportunities. Cited on 30 Jan 2017. Available from http://www.intechopen.com/books/references/glucocorticoids-new-recognition-of-our-familiar-friend/corticosteroids-for-skin-delivery-challenges-and-new-formulation-opportunities.
Hill CJH, Rostenberg A. Adverse effects from topical steroids. Cutis. 1978;21:624–8.
Lubach D, Bensmann A, Bonemann U. Steroid-induced dermal atrophy: investigations on discontinuous application. Dermatologica. 1989;179:67–72.
Valencia IC, Kerdel FA. Topical corticosteroids. In: Fitzpatrick’s dermatology in general medicine. 8th ed. New York, NY: McGraw Hill. p. 2659–64.
Correale CE, Walker C, Murphy L, Craig TJ. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician. 1999;60:1199–210.
Mason J, Mason AR, Cork MJ. Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol. 2002;146:351–64.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–15.
Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: a long overdue revisit. Indian Dermatol Online J. 2014;5:416–25.
Chi C, Wang S, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;(10):CD007346. doi:10.1002/14651858.CD007346.pub3.
Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 2007;275:71–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kwatra, G., Mukhopadhyay, S. (2018). Topical Corticosteroids: Pharmacology. In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_2
Download citation
DOI: https://doi.org/10.1007/978-981-10-4609-4_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4608-7
Online ISBN: 978-981-10-4609-4
eBook Packages: MedicineMedicine (R0)